Invention Grant
US07807793B2 Recombinant IL4 antibodies useful in treatment of IL4 mediated disorders
失效
可用于治疗IL4介导的疾病的重组IL4抗体
- Patent Title: Recombinant IL4 antibodies useful in treatment of IL4 mediated disorders
- Patent Title (中): 可用于治疗IL4介导的疾病的重组IL4抗体
-
Application No.: US11493692Application Date: 2006-07-26
-
Publication No.: US07807793B2Publication Date: 2010-10-05
- Inventor: Stephen Dudley Holmes , Mitchell Stuart Gross , Daniel R. Sylvester
- Applicant: Stephen Dudley Holmes , Mitchell Stuart Gross , Daniel R. Sylvester
- Applicant Address: US PA Philadelphia
- Assignee: GlaxoSmithKline LLC
- Current Assignee: GlaxoSmithKline LLC
- Current Assignee Address: US PA Philadelphia
- Agent Jonathan M. Dermott; William T. Han
- Main IPC: C12P21/08
- IPC: C12P21/08 ; A61K39/395
Abstract:
Chimeric and humanized IL4 MAbs derived from affinity MAbs, pharmaceutical compositions containing same, and methods of treatment are provided.
Public/Granted literature
- US20060263853A1 Recombinant IL4 antibodies useful in treatment of IL4 mediated disorders Public/Granted day:2006-11-23
Information query
